FOR IMMEDIATE RELEASE.
For more information, contact:
UTHSC Communications and Marketing
Anne W. Manning
UTHSC’S BYRNE AWARDED NIH GRANT TO DEVELOP VACCINES
The five-year grant is a renewal of a research project to study the damaging effects of chlamydial infection on the genital tract and eye tissue. The ultimate goal is to develop vaccines that will prevent these infections and the long-term damage they cause, especially in women.
Dr. Byrne is currently principal investigator on three additional NIH-sponsored research grants that focus on Chlamydia trachomatis and Chlamydia pneumoniae, and is project director on a NIH contract to study respiratory pathogen vaccine development.
on the UTHSC faculty since 2002, Dr. Byrne is also chairman of the Department
of Molecular Sciences, director of the Centers for Disease Control-approved
BSL-3 (biosafety level-3) laboratory and the
principal investigator on the $18 million NIH-sponsored Regional Biocontainment Laboratory construction grant. Concurrently,
he is director of the Microbial Pathogenesis Center of Excellence in
Internationally recognized in his field, Dr. Byrne is active as a permanent member of several NIH review panels, has published more than 130 research papers, and has presented more than 120 seminars and invited symposia.
to coming to UTHSC, he was on the faculty at the University of
Wisconsin-Madison from 1982 to 2002. He
holds a PhD from the
As the flagship
statewide academic health system, the University of Tennessee Health Science
Center (UTHSC) is focused on a four-pronged mission of education, research,
patient care and community service, all in support of a single goal: to improve
the health of Tennesseans. Offering a broad range of post-graduate training
opportunities, the main campus, with its seven colleges, is in
This study quantifies the economic impact of the UTHSC on the economy of the state of Tennessee for FY2010.
920 Madison Avenue
Memphis, TN 38163
Phone: (901) 448-5544
Fax: (901) 448-8640